Effective alternative for surgery in benign goitres casuing symtoms

Clinical outcome of thyroid artery embolization in benign goitres - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/113059

Enrollment

Registered

2026-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E041- Nontoxic single thyroid nodule

Interventions

Intervention1: thyroid artery embolization: thyroid artery embolization is a minimally invasive procedure where a catheter is introduced through femoral access and arteries supplying the nodule or 3/4

Eligibility

Inclusion criteria

Inclusion criteria: Benign lesions of thyroid Bethesda II and III

Exclusion criteria

Exclusion criteria: Pregnancy Chronic kidney disease Allergy to contrast

Design outcomes

Primary

Measure	Time frame
TO SEE THE CLINICAL OUTCOME OF THYROID ARTERY EMBOLIZATIUON IN BENIGN GOITRESTimepoint: The patient will be assessed at 1 week, 1 month and 4 months for size reduction of goitre abd thyroid harmone levels.	—

Secondary

Measure	Time frame
NILTimepoint:	—

Countries

India

Contacts

Public ContactKarthiram Raghuraman

Safdarjung hospital

drpuneet06@gmail.com09811925760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026